AIMEDBIO
IR
ENG
KOR
ABOUT US
Overview
Leadership
Corporate Governance
R&D
AimedBio’s Drug Development
P-ADC™
Pipeline
IR
Disclosure
Stock
Financial Information
PR
Notice
Press Release
Data Room
CAREERS
Our Culture
Recruitment Process
Job Opportunities
Disclosure
70 posts
NO.
Title
Date
Author
70
Material Management Information related to Judgment of Investment (ODS025 기술이전계약 관련 마일스톤 기술료 수령)
2026-10-27
에임드바이오
69
[Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)
2026-09-22
에임드바이오
68
Report on status of specific securities, etc. owned by executives and major shareholders
2026-09-18
안선희
67
[Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)
2026-09-02
에임드바이오
66
[Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)
2026-08-21
에임드바이오
65
[Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)
2026-08-18
에임드바이오
64
Semi-annual Report (2026.06)
2026-08-12
에임드바이오
63
[Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청)
2026-08-10
에임드바이오
62
[Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청)
2026-07-22
에임드바이오
61
Report on the Appointment, Dismissal or Early Retirement of Independent Directors
2026-07-16
에임드바이오
Material Management Information related to Judgment of Investment (ODS025 기술이전계약 관련 마일스톤 기술료 수령)
에임드바이오
2026-10-27
[Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)
에임드바이오
2026-09-22
Report on status of specific securities, etc. owned by executives and major shareholders
안선희
2026-09-18
[Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)
에임드바이오
2026-09-02
[Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)
에임드바이오
2026-08-21
[Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인)
에임드바이오
2026-08-18
Semi-annual Report (2026.06)
에임드바이오
2026-08-12
[Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청)
에임드바이오
2026-08-10
[Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청)
에임드바이오
2026-07-22
Report on the Appointment, Dismissal or Early Retirement of Independent Directors
에임드바이오
2026-07-16
1
2
3
4
5